Language
GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand | Reuters

News

HomeHome / News / GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand | Reuters
search
RECENT NEWS

Jun 21, 2023

Odyssey Marine Exploration Announces Partnership with Ocean Minerals LLC for a New Cook Islands Exploration Project

Aug 01, 2023

Analysis of the impact of DGAT1 p.M435L and p.K232A variants on pre

Sep 06, 2023

Could ultra

Oct 10, 2023

Sunrise Group among the world's top ten chemical distributors

Oct 14, 2023

Orally Disintegrating Tablet Excipient Market Research Report 2023

SEND YOUR INQUIRY
SUBMIT

Oct 30, 2024

GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand | Reuters

Sign up here. Reporting by Yadarisa Shabong in Bengaluru and Maggie Fick in London; Editing by Rashmi Aich and Jane Merriman Our Standards: The Thomson Reuters Trust Principles., opens new tab Thomson

Sign up here.

Reporting by Yadarisa Shabong in Bengaluru and Maggie Fick in London; Editing by Rashmi Aich and Jane Merriman

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Thomson Reuters

Maggie is a Britain-based reporter covering the European pharmaceuticals industry with a global perspective. In 2023, Maggie's coverage of Danish drugmaker Novo Nordisk and its race to increase production of its new weight-loss drug helped the Health & Pharma team win a Reuters Journalists of the Year award in the Beat Coverage of the Year category. Since November 2023, she has also been participating in Reuters coverage related to the Israel-Hamas war. Previously based in Nairobi and Cairo for Reuters and in Lagos for the Financial Times, Maggie got her start in journalism in 2010 as a freelancer for The Associated Press in South Sudan.